Vaxcyte (NASDAQ:PCVX) Coverage Initiated at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of Vaxcyte (NASDAQ:PCVX – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Vaxcyte’s FY2025 earnings at ($5.10) EPS. A number of other equities research analysts also recently commented on PCVX. Needham & […]
Cantor Fitzgerald assumed coverage on shares of Vaxcyte (NASDAQ:PCVX – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Vaxcyte’s FY2025 earnings at ($5.10) EPS. A number of other equities research analysts also recently commented on PCVX. Needham & […]
